Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
27.00
+0.85 (3.25%)
May 19, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $57.71. The average 1-year stock price forecast is 113.74% higher than the current stock price, while the lowest is $48 (+77.78%) and the highest is $75 (+177.78%).
Price Target: $57.71 (+113.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $62 → $66 | Buy | Maintains | $62 → $66 | +144.44% | May 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +85.19% | Apr 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | +129.63% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +122.22% | Mar 19, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +77.78% | Feb 27, 2026 |
Financial Forecast
Revenue This Year
62.04M
from 16.80M
Increased by 269.41%
Revenue Next Year
113.27M
from 62.04M
Increased by 82.57%
EPS This Year
-9.19
from -23.04
EPS Next Year
-1.69
from -9.19
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 67.7M | 126.0M | ||||||
| Avg | 62.0M | 113.3M | ||||||
| Low | 55.3M | 99.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 302.8% | 103.1% | ||||||
| Avg | 269.4% | 82.6% | ||||||
| Low | 229.3% | 60.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -3.33 | 0.16 | |||
| Avg | -9.19 | -1.69 | |||
| Low | -13.01 | -2.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.